Skip to main content

Vertebral metastatic disease: A paradigm shift.

Journal articles  - Journal Article, Review
Nguyen, A; Trivedi, T; O'Callaghan, E; Yoo, S; Zachem, T; Ahmed, R; De La Garza Ramos, R; Charest-Morin, R; Bilsky, MH; Sciubba, D; Clarke, M ...
Published in: Neurooncol Adv
May 2026

Vertebral metastatic disease results from many types of cancer and can have a devastating impact on patient mobility, psychological health, quality of life, and ultimately overall patient survival. However, the development of radiotherapy and surgical techniques has rapidly surged in conjunction with ongoing advances in basic science and translational studies. In this review, we discuss the paradigm shift in our understanding of the epidemiology and treatment algorithms for spinal oncology, ranging from preoperative optimization strategies, radiation and surgical techniques, the utilization of molecular markers and targeted therapeutics in medical oncology, and prognostication tools that underscore a new multidisciplinary approach to spinal oncology care.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neurooncol Adv

DOI

EISSN

2632-2498

Publication Date

May 2026

Volume

8

Issue

Suppl 3

Start / End Page

iii21 / iii36

Location

England
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nguyen, A., Trivedi, T., O’Callaghan, E., Yoo, S., Zachem, T., Ahmed, R., … Goodwin, C. R. (2026). Vertebral metastatic disease: A paradigm shift. Neurooncol Adv, 8(Suppl 3), iii21–iii36. https://doi.org/10.1093/noajnl/vdag011
Nguyen, Annee, Trupti Trivedi, Ellen O’Callaghan, Seeley Yoo, Tanner Zachem, Ramzy Ahmed, Rafael De La Garza Ramos, et al. “Vertebral metastatic disease: A paradigm shift.Neurooncol Adv 8, no. Suppl 3 (May 2026): iii21–36. https://doi.org/10.1093/noajnl/vdag011.
Nguyen A, Trivedi T, O’Callaghan E, Yoo S, Zachem T, Ahmed R, et al. Vertebral metastatic disease: A paradigm shift. Neurooncol Adv. 2026 May;8(Suppl 3):iii21–36.
Nguyen, Annee, et al. “Vertebral metastatic disease: A paradigm shift.Neurooncol Adv, vol. 8, no. Suppl 3, May 2026, pp. iii21–36. Pubmed, doi:10.1093/noajnl/vdag011.
Nguyen A, Trivedi T, O’Callaghan E, Yoo S, Zachem T, Ahmed R, De La Garza Ramos R, Charest-Morin R, Bilsky MH, Sciubba D, Clarke M, Tatsui C, Shin JH, Laufer I, Barzilai O, Gokaslan ZL, Sahgal A, Weber M, Sullivan PLZ, Dea N, Lazáry Á, Mullikin T, Goodwin CR. Vertebral metastatic disease: A paradigm shift. Neurooncol Adv. 2026 May;8(Suppl 3):iii21–iii36.

Published In

Neurooncol Adv

DOI

EISSN

2632-2498

Publication Date

May 2026

Volume

8

Issue

Suppl 3

Start / End Page

iii21 / iii36

Location

England